YOUR
Search

    29.05.2026

    ADVANT M&A Deal Point Study 2026


    The ADVANT M&A Deal Point Study 2026 delivers a rigorous, data-driven analysis of current contracting practice across European M&A transactions. Based on 217 deals executed in 2025 across three jurisdictions – Germany, France and Italy – the Study provides detailed market benchmarks on eleven core deal points, from purchase price structures and earn-out mechanics to liability regimes and dispute resolution clauses. For practitioners advising on buy-side or sell-side mandates, the Study offers authoritative insight into prevailing market standards and emerging trends. Download the full report to access the findings.

    ADVANT Beiten and ADVANT Nctm advise JLL Partners on the acquisition of Life Couriers
    Berlin/Milan, August 19, 2026 – The international law firm ADVANT, with teams…
    Read more
    ADVANT Beiten strengthens its conflict resolution practice and German-Turkish advisory business with the appointment of Dr Gökçe Uzar Schüller as an equity partner
    Frankfurt, 18 August 2026 – ADVANT Beiten is further expanding its international…
    Read more
    Simplified procedures for the German LLC when convening a shareholders' meeting
    The Higher Regional Court of Celle (OLG Celle) clarified for a German limited…
    Read more
    ADVANT Beiten Advises Banyan Software on the Acquisition of tec4U-Solutions GmbH
    Berlin/Freiburg, 1 July 2026 - The international law firm ADVANT Beiten has…
    Read more
    ADVANT Beiten Advises Ningbo Cixing on the acquisition of selected STOLL assets from KARL MAYER
    Berlin, 25 June 2026 - The international law firm ADVANT Beiten has provided…
    Read more
    A New Era of Scrutiny: Analysing the Reformed EU FDI Screening Regulation and Its Impact on Germany
    Foreign direct investment (FDI) plays a critical role in fostering economic…
    Read more
    ADVANT Beiten partnered with Island Green Capital on Stake in Isar Aerospace
    Berlin, 12 June 2026 - The international law firm ADVANT Beiten has provided…
    Read more
    ADVANT Advises Pidigi S.p.A. on the Acquisition of Key Assets of Sympatex Technologies GmbH from Insolvency Proceedings
    Munich, 5 May 2026 – ADVANT Beiten has assisted the Italian firm Pidigi S.p.A.…
    Read more
    Start of first biologics rebate agreements: ADVANT Beiten advises spectrumK
    Berlin, 4 June 2026 - Effective 1 June 2026, spectrumK's first exclusive…
    Read more